Justyna Mysliwy

Justyna Mysliwy PhD Justyna is the Executive Director of Iksuda’s Research programs. She has over 10 years of industry experience in the development and pre-clinical exemplification of ADCs in multiple models. Justyna brings comprehensive knowledge of bioconjugation chemistry, pharmacology, and an understanding of ADC design and development. Having completed her Ph.D. (University of Kiel, Germany), characterising the mode of action and physicochemical properties of antibacterial proteins, Justyna undertook her post-doctoral studies at the Centre of Advanced Research in Biotechnology (Maryland), focused on the structural changes in G protein signalling. Justyna joined Almac in 2009 to work on the development of their proprietary technology focused on site-specific protein conjugation, before moving to Iksuda Therapeutics Ltd (previously Glythera Ltd) in 2013.